NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells

Cancer Research

Volumn 72, Issue 16, 2012, Pages 4085-4096

  Yap, Kai Lee ^a   Fraley, Stephanie I ^b   Thiaville, Michelle M ^c,f   Jinawath, Natini ^c,g   Nakayama, Kentaro ^d   Wang, Jianlong ^e   Wang, Tian Li ^c   Wirtz, Denis ^b   Shih, Ie Ming ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d SHIMANE UNIVERSITY   (Japan)

^e MOUNT SINAI MEDICAL CENTER   (United States)

^f LOUISIANA STATE UNIVERSITY   (United States)

^g MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; NUCLEUS ACCUMBENS ASSOCIATED 1 PROTEIN; PROFILIN; PROFILIN I; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOKINESIS; EPITHELIUM CELL; LUNG FIBROBLAST; MICROSCOPY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION;

ACTINS; CYTOKINESIS; HEK293 CELLS; HELA CELLS; HUMANS; MCF-7 CELLS; NEOPLASM PROTEINS; NEOPLASMS; PHENOTYPE; PROFILINS; REPRESSOR PROTEINS;

EID: 84865145768     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-0302     Document Type: Article

References (40)

1. Perez-Torrado R, Yamada D, Defossez PA. Born to bind: the BTB protein-protein interaction domain. Bioessays 2006;28:1194-202. (Pubitemid 44925439)
2. Bardwell VJ, Treisman R. The POZ domain: a conserved protein-protein interaction motif. Genes Dev 1994;8:1664-77. (Pubitemid 24236245)
3. Albagli O, Dhordain P, Deweindt C, Lecocq G, Leprince D. The BTB/POZ domain: a new protein-protein interaction motif common to DNA-and actin-binding proteins. Cell Growth Differ 1995;6:1193-8.
4. Cha XY, Pierce RC, Kalivas PW, Mackler SA. NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration. J Neurosci 1997;17:6864-71. (Pubitemid 27427864)
5. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006;444:364-8. (Pubitemid 44764111)
6. Ma T, Wang Z, Guo Y, Pei D. The C-terminal pentapeptide of Nanog tryptophan repeat domain interacts with Nac1 and regulates stem cell proliferation but not pluripotency. J Biol Chem 2009;284:16071-81.
7. Nakayama K, Nakayama N, Davidson B, Sheu JJ, Jinawath N, Santillan A, et al. A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival. Proc Natl Acad Sci U S A 2006;103:18739-44. (Pubitemid 44913480)
8. Nakayama K, Nakayama N, Wang TL, Shih IM. NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor. Cancer Res 2007;67:8058-64. (Pubitemid 47395140)
9. Jinawath N, Vasoontara C, Yap KL, Thiaville MM, Nakayama K, Wang TL, et al. NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway. Oncogene 2009;28:1941-8.
10. Nakayama K, Rahman MT, Rahman M, Yeasmin S, Ishikawa M, Katagiri A, et al. Biological role and prognostic significance of NAC1 in ovarian cancer. Gynecol Oncol 2010;119:469-78.
11. Shih IM, Nakayama K, Wu G, Nakayama N, Zhang J, Wang TL. Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma. Mod Pathol 2011;24:638-45.
12. Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, et al. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas. Hum Pathol 2011;43:506-19.
13. Yeasmin S, Nakayama K, Ishibashi M, Katagiri A, Iida K, Purwana IN, et al. Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis. Clin Cancer Res 2008;14:1686-91. (Pubitemid 351469452)
14. Ishibashi M, Nakayama K, Yeasmin S, Katagiri A, Iida K, Nakayama N, et al. Expression of a BTB/POZ protein, NAC1, is essential for the proliferation of normal cyclic endometrial glandular cells and is up-regulated by estrogen. Clin Cancer Res 2009;15:804-11.
15. Ishikawa M, Nakayama K, Yeasmin S, Katagiri A, Iida K, Nakayama N, et al. NAC1, a potential stem cell pluripotency factor expression in normal endometrium, endometrial hyperplasia and endometrial carcinoma. Int J Oncol 2010;36:1097-103.
16. Zhang Y, Cheng Y, Ren X, Zhang L, Yap KL, Wu H, et al. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response. Oncogene 2012;31:1055-64.
17. Ueda SM, Yap KL, Davidson B, Tian Y, Murthy V, Wang TL, et al. Expression of fatty acid synthase depends on NAC1 and is associated with recurrent ovarian serous carcinomas. J Oncol 2010;2010:285191.
18. Wu PH, Hung SH, Ren T, Shih Ie M, Tseng Y. Cell cycle-dependent alteration in NAC1 nuclear body dynamics and morphology. Phys Biol 2011;8:015005.
19. Bottcher RT, Wiesner S, Braun A, Wimmer R, Berna A, Elad N, et al. Profilin 1 is required for abscission during late cytokinesis of chondrocytes. EMBO J 2009;28:1157-69.
20. Pollard TD. A guide to simple and informative binding assays. Mol Biol Cell 2010;21:4061-7.
21. Stoeck A, Shang L, Dempsey PJ. Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth. J Cell Sci 2010;123:2319-31.
22. Balasubramanian MK, Hirani BR, Burke JD, Gould KL. The Schizosaccharomyces pombe cdc3+ gene encodes a profilin essential for cytokinesis. J Cell Biol 1994;125:1289-301.
23. Korenbaum E, Nordberg P, Bjorkegren-Sjogren C, Schutt CE, Lindberg U, Karlsson R. The role of profilin in actin polymerization and nucleotide exchange. Biochemistry 1998;37:9274-83. (Pubitemid 28307681)
24. Paavilainen VO, Bertling E, Falck S, Lappalainen P. Regulation of cytoskeletal dynamics by actin-monomer-binding proteins. Trends Cell Biol 2004;14:386-94. (Pubitemid 38891708)
25. Schluter K, Schleicher M, Jockusch BM. Effects of single amino acid substitutions in the actin-binding site on the biological activity of bovine profilin I. J Cell Sci 1998;:3261-73. (Pubitemid 28563030)
26. Wittenmayer N, Jandrig B, Rothkegel M, Schluter K, Arnold W, Haensch W, et al. Tumor suppressor activity of profilin requires a functional actin binding site. Mol Biol Cell 2004;15:1600-8. (Pubitemid 38401811)
27. Pollard TD. Mechanics of cytokinesis in eukaryotes. Curr Opin Cell Biol 2010;22:50-6.
28. Glotzer M. The molecular requirements for cytokinesis. Science 2005;307:1735-9. (Pubitemid 40388608)
29. Barr FA, Gruneberg U. Cytokinesis: placing and making the final cut. Cell 2007;131:847-60. (Pubitemid 350138092)
30. Piekny A, Werner M, Glotzer M. Cytokinesis: welcome to the Rho zone. Trends Cell Biol 2005;15:651-8. (Pubitemid 41713966)
31. Lacroix B, Maddox AS. Cytokinesis, ploidy and aneuploidy. J Pathol 2012;226:338-51.
32. Pollard TD, Cooper JA. Actin, a central player in cell shape and movement. Science 2009;326:1208-12.
33. Tsunoda K, Oikawa H, Tada H, Tatemichi Y, Muraoka S, Miura S, et al. Nucleus accumbens-associated 1 contributes to cortactin deacetylation and augments the migration of melanoma cells. J Invest Dermatol 2011;131:1710-9.
34. Edamatsu M, Hirono M, Watanabe Y. Tetrahymena profilin is localized in the division furrow. J Biochem 1992;112:637-42.
35. Stead MA, Carr SB, Wright SC. Structure of the human Nac1 POZ domain. Acta Crystallogr Sect F Struct Biol Cryst Commun 2009;65:445-9.
36. Nurnberg A, Kitzing T, Grosse R. Nucleating actin for invasion. Nat Rev Cancer 2011;11:177-87.
37. Polo JM, Dell'Oso T, Ranuncolo SM, Cerchietti L, Beck D, Da Silva GF, et al. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat Med 2004;10:1329-35. (Pubitemid 40022714)
38. Cerchietti LC, Ghetu AF, Zhu X, Da Silva GF, Zhong S, Matthews M, et al. A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo. Cancer Cell 2010;17:400-11.
39. Cerchietti LC, Yang SN, Shaknovich R, Hatzi K, Polo JM, Chadburn A, et al. A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo. Blood 2009;113:3397-405.
40. Krzywicka-Racka A, Sluder G. Repeated cleavage failure does not establish centrosome amplification in untransformed human cells. J Cell Biol 2011;194:199-207.